Long-term Cardiovascular Risk in Cured Cushing's Patients

This study has been withdrawn prior to enrollment.
(No patients were enrolled.)
Sponsor:
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00881283
First received: April 13, 2009
Last updated: March 5, 2010
Last verified: March 2010
  Purpose

The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.


Condition
Cushing's Disease

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Role of Adipokines in Long-term Cardiovascular Risk in Cured Cushing's Patients

Resource links provided by NLM:


Further study details as provided by Massachusetts General Hospital:

Biospecimen Retention:   Samples With DNA

serum, urine


Estimated Enrollment: 40
Study Start Date: October 2008
Estimated Study Completion Date: October 2010
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
cured Cushing's disease

  Eligibility

Ages Eligible for Study:   35 Years to 55 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Cured Cushing's disease

Criteria

Inclusion Criteria:

  • patients who have been cured of Cushing's disease at least 5 years ago.

Exclusion Criteria:

  • patients who have been cured of Cushing's disease more than 15 years ago.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00881283

Locations
United States, Massachusetts
Neuroendocrine Clinical Center
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
Principal Investigator: Anne Klibanski, MD Massachusetts General Hospital
  More Information

No publications provided

Responsible Party: Anne Klibanski, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00881283     History of Changes
Other Study ID Numbers: 2008-p-001379
Study First Received: April 13, 2009
Last Updated: March 5, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
Cushing's disease

Additional relevant MeSH terms:
Cushing Syndrome
Pituitary ACTH Hypersecretion
Adrenocortical Hyperfunction
Adrenal Gland Diseases
Endocrine System Diseases
Hyperpituitarism
Pituitary Diseases
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 22, 2014